Dose Cancer Research Results
Dose, Dosage: Click to Expand ⟱
| Source: |
| Type: |
Drug dosage vs efficacy, and actual dosage number of research papers.
|
Cerv, Cervical Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
ROS↑, lipid-P↑, MMP↓, GSH↓, TumCCA↑, Apoptosis↑, Necroptosis↑, TumCD↑, Dose↝,
TumCD↑, eff↑, TumAuto↑, ER Stress↑, Paraptosis↑, GRP78/BiP↓, Dose↝,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
Dose↝, TumCMig↓, Apoptosis↑, necrosis↑, ROS↑, eff↑,
ROS↑, Dose↝, Bcl-2↓, BAX↑, ER Stress↑,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
TrxR↓, Dose↝, eff↑,
| - |
in-vitro, |
Lung, |
H1299 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
Glycolysis↓, GlucoseCon↓, lactateProd↓, PKM2↓, mTOR↓, Hif1a↓, selectivity↑, Dose↝, tumCV↓,
other↝, Glycolysis↓, LDHA↓, Hypoxia↓, Apoptosis↑, lactateProd↓, ATP↓, mt-ROS↑, DNAdam↑, lipid-P↑, AMPK↑, p‑S6K↓, TumCP↓, Dose↝, selectivity↑, i-MDA↑, mtDam↑,
p‑Akt↓, Apoptosis↑, TumCG↓, Dose↝, PI3K↓, eff↑, ATP↓, OCR↓, TumCCA↑, IGF-1↓, angioG↓, TumCI↓,
| - |
in-vitro, |
Ovarian, |
OVCAR-3 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
NA, |
NA, |
OV1369 |
|
|
|
Dose↝, TumCD↑, eff↓, Casp↑, H2O2↑, i-ROS↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Laryn, |
FaDu |
|
|
|
RadioS↑, TumCD↑, BRCA2↓, Dose↝, BloodF↑, ROS↑, Imm↑,
AhR↑, UBE2L3/UBCH7↑, Dose↝,
| - |
in-vitro, |
SCC, |
KYSE150 |
|
|
|
- |
in-vitro, |
SCC, |
KYSE450 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
ChemoSen⇅, HSP70/HSPA5↑, Beclin-1/ATG6⇅, Dose↝, TumVol⇅, TumW⇅,
| - |
in-vitro, |
CRC, |
DLD1 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Liver, |
HUH7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
*antiOx↑, *AntiBio↑, *AntiDiabetic↑, *AntiCan↑, Dose↝, TumCP↓, ER Stress↑, Apoptosis↑, Bcl-2↓, BAX↑, Casp3↑, Casp9↑, Casp12↝, NF-kB↓, P53↑,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
Melanoma, |
A2780S |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
eff↑, Dose↝, Dose↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
sarcoma, |
S180 |
|
|
|
tumCV↓, ROS↑, *GutMicro↑, BioAv↑, other↝, Dose↝,
Showing Research Papers: 1 to 15 of 15
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 15
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
UBE2L3/UBCH7↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
GSH↓, 1, H2O2↑, 1, lipid-P↑, 2, i-MDA↑, 1, ROS↑, 5, i-ROS↑, 1, mt-ROS↑, 1, TrxR↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ATP↓, 2, MMP↓, 1, mtDam↑, 1, OCR↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, GlucoseCon↓, 1, Glycolysis↓, 2, lactateProd↓, 2, LDHA↓, 1, PKM2↓, 1, p‑S6K↓, 1,
Cell Death(tgid=5) ⓘ
AhR↑, 1, p‑Akt↓, 1, Apoptosis↑, 5, BAX↑, 2, Bcl-2↓, 2, Casp↑, 1, Casp12↝, 1, Casp3↑, 1, Casp9↑, 1, Necroptosis↑, 1, necrosis↑, 1, Paraptosis↑, 1, TumCD↑, 4,
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 2, tumCV↓, 2,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 3, GRP78/BiP↓, 1, HSP70/HSPA5↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
Beclin-1/ATG6⇅, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
BRCA2↓, 1, DNAdam↑, 1, P53↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
IGF-1↓, 1, mTOR↓, 1, PI3K↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
TumCI↓, 1, TumCMig↓, 1, TumCP↓, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, Hif1a↓, 1, Hypoxia↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Imm↑, 1, NF-kB↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 1, ChemoSen⇅, 1, Dose↑, 1, Dose↝, 15, eff↓, 1, eff↑, 5, RadioS↑, 1, selectivity↑, 2,
Clinical Biomarkers(tgid=22) ⓘ
BloodF↑, 1,
Functional Outcomes(tgid=23) ⓘ
TumVol⇅, 1, TumW⇅, 1,
Total Targets: 67
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiBio↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
GutMicro↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiDiabetic↑, 1,
Total Targets: 5
Scientific Paper Hit Count for: Dose, Dosage
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:29 Cells:% prod#:% Target#:1114 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page